| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.3M | +2.9% |
| Cost of Revenue | $10.2M | +20.7% |
| Gross Profit | -$5.9M | -38.3% |
| R&D Expense | $102.5M | -6.5% |
| SG&A Expense | $31.8M | +2.2% |
| Operating Income | -$147.8M | +2.7% |
| Pre-tax Income | -$149.3M | -1.4% |
| Income Tax | $0 | — |
| Net Income | -$149.3M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.5M | -42.8% |
| Short-term Investments | $182.5M | -28.8% |
| Accounts Receivable | $628K | -78.2% |
| Inventory | $2.4M | -19.6% |
| Current Assets | $229.2M | -31.6% |
| Total Assets | $257.4M | -27.8% |
| Current Liabilities | $18.4M | -15.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$118.8M | -8.1% |
| Capital Expenditures | $6.1M | -17.9% |
| Investing Cash Flow | $69.3M | -37.5% |
| Financing Cash Flow | $20.7M | +5703.3% |
| Free Cash Flow | -$124.9M | -6.5% |
| -1.4% |
| EPS (Basic) | -$0.66 | +2.9% |
| EPS (Diluted) | -$0.66 | +2.9% |
| Total Liabilities |
| $28.9M |
| +8.4% |
| Stockholders' Equity | $228.4M | -30.8% |